ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,700,000 | +58.6% | 50,564 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $2,964,000 | +13.0% | 49,764 | +29.4% | 0.00% | 0.0% |
| Q2 2021 | $2,623,000 | -3.7% | 38,467 | -2.0% | 0.00% | 0.0% |
| Q1 2021 | $2,724,000 | +2.8% | 39,245 | +13.8% | 0.00% | 0.0% |
| Q4 2020 | $2,650,000 | +1.5% | 34,491 | -1.2% | 0.00% | 0.0% |
| Q3 2020 | $2,612,000 | +24.3% | 34,926 | +4.6% | 0.00% | 0.0% |
| Q2 2020 | $2,102,000 | +44.8% | 33,393 | -3.4% | 0.00% | 0.0% |
| Q1 2020 | $1,452,000 | -11.1% | 34,564 | -3.8% | 0.00% | 0.0% |
| Q4 2019 | $1,633,000 | +22.0% | 35,943 | +22.8% | 0.00% | 0.0% |
| Q3 2019 | $1,339,000 | -11.5% | 29,264 | +13.4% | 0.00% | 0.0% |
| Q2 2019 | $1,513,000 | +66.6% | 25,796 | +27.3% | 0.00% | 0.0% |
| Q1 2019 | $908,000 | +17.5% | 20,266 | +2.1% | 0.00% | 0.0% |
| Q4 2018 | $773,000 | -9.9% | 19,852 | +6.5% | 0.00% | 0.0% |
| Q3 2018 | $858,000 | +147.3% | 18,634 | +134.5% | 0.00% | – |
| Q2 2018 | $347,000 | +0.6% | 7,946 | -9.1% | 0.00% | – |
| Q1 2018 | $345,000 | +2.4% | 8,743 | -11.6% | 0.00% | – |
| Q4 2017 | $337,000 | +27.7% | 9,894 | -4.5% | 0.00% | – |
| Q3 2017 | $264,000 | +125.6% | 10,356 | +46.8% | 0.00% | – |
| Q2 2017 | $117,000 | – | 7,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |